Bellerophon Therapeutics
BLPH
#11323
Rank
NZ$0.26 M
Marketcap
NZ$0.02181
Share price
-36.84%
Change (1 day)
-79.35%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): NZ-$1.46

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$1.53. In 2017 the company made an earnings per share (EPS) of NZ-$37.62 an increase over its 2016 EPS that were of NZ-$43.62.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.46
2017NZ-$37.62-13.75%
2016NZ-$43.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
NZ$4.91-421.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.56 67.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
NZ$7.52-592.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
NZ$2.40-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA